Aastrid develops and manufactures following molecules: -
1. Key starting Materials (KSMs)
2. Advanced intermediates for APIs having therapeutic categories like antipsychotic, antihypertensive, analgesic etc.
3. Specialty chemicals for anticorrosion and electroplating applications.
Core strengths of Aastrid are: -
1. Experienced R and D facility with more than 500+ product developments.
2. State of the art manufacturing facility.
3. Compliance to cGMP standards to comply regulatory requirements of the world.
4. Well qualified and experienced team.
5. High standard of safety and health precautions.
6. Focus on sustainability.
7. Customer approval of top Companies globally.
8. 100% legally compliant.
Aastrid specializes in following reactions
1. Friedal - crafts reactions
2. High Pressure Catalytic Hydrogenation
3. Nitration
4. Bromination
5. Sodium Borohydrate Reduction
6. Vitride Reaction
7. Butyl Lithium Reaction
8. Wittig reactions
9. Grignard reactions
10. Chiral synthetic Chemistry
11. Reductive Amination
12. Suzuki coupling
13. Aldol Condensation
14. Dearomatisation
15. Esterification
Two manufacturing sites located at MIDC, Mahad, Maharashtra, India.
120 KL
ISO 9001:2015 and cGMP from TUV nord for both the manufacturing units.
No. Since being into intermediate manufacturing these authorities will not directly audit our facility. All these authorities only audit our site if any of our API manufacturing customer audit will trigger our site audit.
The details are as follows: -
Unit-2 FEI number: 3022338319
DUNs number application is in process.
Yes. We can support these authorities’ inspection for our Unit-2.
Some of our major customers are Abbvie, Olon, Curia, Sequens, Sun Pharma, Recipharm, Laurus Labs, Wavelength, Dr Reddys, Evonik, Alembic, Glenmark, Aarti Industries Ltd, Biocon, Lupin, Piramal Pharma Solutions, Hetero, MSN, Natco, Icrom, Emcure, Teva, Optimus, Chori, Centaur, Uquifa, Viatris, Torrent Pharma
70 % domestic and 30 % Export.